Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

WR 151327

Known as: 1-Propanethiol, 3-((3-(methylamino)propyl)amino)-, dihydrogen phosphate (ester), WR-151327 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Combined injuries, which are expected after a radiation dispersal device release or nuclear weapon detonation, are the… Expand
2001
2001
The effect of combining a radiation‐protective phosphorothioate with another agent was investigated in an attempt to increase… Expand
2000
2000
PURPOSE To determine the efficacy of WR-151327 (WR) [S-3-(3-methylaminopropylamino) propylphosphorothioic acid; (CH3-HN-(CH2)3-NH… Expand
1994
1994
Clinical trials are in progress to evaluate radio- and chemoprotection by the aminothiol 2-[(3-aminopropyl)amino]ethanethiol… Expand
  • table 2
  • table 1
  • table 3
  • table 4
  • table 5
1994
1994
Reducing agents such as glutathione (GSH), glutathione ester (GSE), and N-acetylcysteine (NAC) have been shown to suppress the… Expand
1994
1994
Spaceflight personnel need treatment options that would enhance survival from radiation and would not disrupt task performance… Expand
1992
1992
Studies were made on the radioprotective and toxic effects of orally administered WR-151327 in male CD2F1 mice. The lowest dose… Expand
1991
1991
The mutagenic and carcinogenic properties of fission-spectrum neutrons (KERMA-weighted mean energy of 0.85 MeV) from Argonne… Expand
1990
1990
The systemic effects of the radiation protective agent, S-3-(3-methylaminopropylamino) propylphosphorothioic acid (WR-151327… Expand
1987
1987
Two phosphorothioate compounds, WR-2721 and WR-151327, were examined for their radioprotective efficacies against the effects of… Expand